Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 10, 2009 - Issue 8
Submit an article Journal homepage
334
Views
12
CrossRef citations to date
0
Altmetric
Reviews

Pharmacotherapy in stroke rehabilitation

Anna Członkowska Institute of Psychiatry and Neurology, 2nd Dept of Neurology, 9 Sobieskiego Str., 02-957 Warsaw, Poland +48 22 4582 537; +48 22 842 40 23; [email protected]; Medical University, Department of Clinical Pharmacology, Warsaw, Poland
, MD PhD &
Marcin Leśniak Institute of Psychiatry and Neurology, 2nd Dept of Neurology, 9 Sobieskiego Str., 02-957 Warsaw, Poland +48 22 4582 537; +48 22 842 40 23; [email protected]
, MSc
Pages 1249-1259 | Published online: 23 May 2009

Bibliography

  • Chen J, Chopp M. Neurorestorative treatment of stroke: cell and pharmacological approaches. NeuroRx 2006;3(4):466-73
  • Hummel FC, Cohen LG. Drivers of brain plasticity. Curr Opin Neurol 2005;18(6):667-74
  • Wagner T, Valero-Cabre A, Pascual-Leone A. Noninvasive human brain stimulation. Annu Rev Biomed Eng 2007;9:527-65
  • Cramer SC. Repairing the human brain after stroke. II: restorative therapies. Ann Neurol 2008;63(5):549-60
  • Seil F. Recovery and repair issues after stroke from the scientific perspective. Curr Opin Neurol 1997;10:49-51
  • Carmichael ST. Cellular and molecular mechanisms of neural repair after stroke: making waves. Ann Neurol 2006;59(5):735-42
  • Rossini PM, Pauri F. Neuromagnetic integrated methods tracking human brain mechanisms of sensorimotor areas ‘plastic’ reorganisation. Brain Res Brain Res Rev 2000;33(2-3):131-54
  • Rijntjes M, Weiller C. Recovery of motor and language abilities after stroke: the contribution of functional imaging. Prog Neurobiol 2002;66(2):109-22
  • Butefisch CM, Kleiser R, Seitz RJ. Post-lesional cerebral reorganisation: evidence from functional neuroimaging and transcranial magnetic stimulation. J Physiol Paris 2006;99(4-6):437-54
  • Taupin P. Adult neurogenesis pharmacology in neurological diseases and disorders. Expert Rev Neurother 2008;8(2):311-20
  • Zorowitz RD. Road to recovery: drugs used in stroke rehabilitation. Expert Rev Neurother 2004;4(2):219-31
  • Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999;30(12):2752-8
  • O'Collins VE, Macleod MR, Donnan GA, et al. 1,026 experimental treatments in acute stroke. Ann Neurol 2006;59(3):467-77
  • Członkowski A, Mirowska-Guzel D, Członkowska A. Therapy of stroke – from experimental studies to clinical trials. Pharmacol Rep 2007;59(Suppl 1):123-8
  • Muresanu DF. Neuroprotection and neuroplasticity – a holistic approach and future perspectives. J Neurol Sci 2007;257(1-2):38-43
  • Donnan GA. The 2007 Feinberg lecture: a new road map for neuroprotection. Stroke 2008;39(1):242
  • Cramer SC. Repairing the human brain after stroke: I. mechanisms of spontaneous recovery. Ann Neurol 2008;63(3):272-87
  • Rijntjes M. Mechanisms of recovery in stroke patients with hemiparesis or aphasia: new insights, old questions and the meaning of therapies. Curr Opin Neurol 2006;19(1):76-83
  • Bütefisch CM, Netz J, Wessling M, et al. Remote changes in cortical excitability after stroke. Brain 2003;126:470-481
  • Baron JC. Stroke research in the modern era: images versus dogmas. Cerebrovasc Dis 2005;20(3):154-63
  • Seitz RJ, Azari NP, Knorr U, et al. The role of diaschisis in stroke recovery. Stroke 1999;30(9):1844-50
  • Kreisel SH, Bazner H, Hennerici MG. Pathophysiology of stroke rehabilitation: temporal aspects of neuro-functional recovery. Cerebrovasc Dis 2006;21(1-2):6-17
  • Goldstein LB. Influence of common drugs and related factors on stroke outcome. Curr Opin Neurol 1997;10:52-7
  • Goldstein LB, Davis JN. Clonidine impairs recovery of beam-walking after a sensorimotor cortex lesion in the rat. Brain Res 1990;508(2):305-9
  • Goldstein LB. Common drugs may influence motor recovery after stroke. the Sygen in Acute Stroke Study investigators. Neurology 1995;45(5):865-71
  • Stroemer RP, Kent TA, Hulsebosch CE. Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats. Stroke 1998;29(11):2381-93; discussion 2393-5
  • Martinsson L, Hardemark HG, Eksborg S. Amphetamines for improving recovery after stroke (review). United States: John Wiley ‘ Sons, Ltd; 2008
  • Mintz M, Tomer R. Exposure to amphetamine after substantia nigra lesion interferes with the process of behavioral recovery. Pharmacol Biochem Behav 1986;25(6):1307-11
  • Martinsson L, Eksborg S. Drugs for stroke recovery: the example of amphetamines. Drugs Aging 2004;21(2):67-79
  • Sonde L, Lokk J. Effects of amphetamine and/or L-dopa and physiotherapy after stroke: a blinded randomized study. Acta Neurol Scand 2007;115(1):55-9
  • Martinsson L, Hardemark HG, Eksborg S. Should amphetamines be given to improve recovery after stroke? Stroke 2007;38:2400-1
  • Gladstone DJ, Danells CJ, Armesto A, et al. Physiotherapy coupled with dextroamphetamine for rehabilitation after hemiparetic stroke: a randomized, double-blind, placebo-controlled trial. Stroke 2006;37(1):179-85
  • Walker-Batson D, Curtis S, Natarajan R, et al. A double-blind, placebo-controlled study of the use of amphetamine in the treatment of aphasia. Stroke 2001;32(9):2093-8
  • Weikop P, Yoshitake T, Kehr J. Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain. Eur Neuropsychopharmacol 2007;17(10):658-71
  • Grade C, Redford B, Chrostowski J, et al. Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch Phys Med Rehabil 1998;79(9):1047-50
  • Poewe W. Non-motor symptoms in Parkinson's disease. Eur J Neurol 2008;15(Suppl 1):14-20
  • Nishino K, Sasaki T, Takahashi K, et al. The norepinephrine precursor L-threo-3, 4-dihydroxyphenylserine facilitates motor recovery in chronic stroke patients. J Clin Neurosci 2001;8(6):547-50
  • Yan HQ, Kline AE, Ma X, et al. Traumatic brain injury reduces dopamine transporter protein expression in the rat frontal cortex. Neuroreport 2002;13(15):1899-901
  • Nutt JG. Pharmacokinetics and pharmacodynamics of levodopa. Mov Disord 2008;23(Suppl 3):S580-4
  • Knecht S, Breitenstein C, Bushuven S, et al. Levodopa: faster and better word learning in normal humans. Ann Neurol 2004;56(1):20-6
  • Scheidtmann K, Fries W, Muller F, Koenig E. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet 2001;358(9284):787-90
  • Restemeyer C, Weiller C, Liepert J. No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo-controlled cross-over pilot study. Restor Neurol Neurosci 2007;25(2):143-50
  • Floel A, Hummel F, Breitenstein C, et al. Dopaminergic effects on encoding of a motor memory in chronic stroke. Neurology 2005;65(3):472-4
  • Mukand JA, Guilmette TJ, Allen DG, et al. Dopaminergic therapy with carbidopa L-dopa for left neglect after stroke: a case series. Arch Phys Med Rehabil 2001;82(9):1279-82
  • Seniów J, Litwin M, Litwin T, et al. New approach to the rehabilitation of poststroke focal cognitive syndrome: effect of levodopa combined with speech and language therapy on functional recovery from aphasia. J Neurol Sci 2008 In press
  • Ashtary F, Janghorbani M, Chitsaz A, et al. A randomized, double-blind trial of bromocriptine efficacy in nonfluent aphasia after stroke. Neurology 2006;66(6):914-6
  • Gupta SR, Mlcoch AG, Scolaro C, Moritz T. Bromocriptine treatment of nonfluent aphasia. Neurology 1995;45(12):2170-3
  • Bragoni M, Altieri M, Di Piero V, et al. Bromocriptine and speech therapy in non-fluent chronic aphasia after stroke. Neurol Sci 2000;21(1):19-22
  • Sabe L, Salvarezza F, Garcia Cuerva A, et al. A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia. Neurology 1995;45(12):2272-4
  • Mandel S, Grunblatt E, Riederer P, et al. Neuroprotective strategies in Parkinson's disease: an update on progress. CNS Drugs 2003;17(10):729-62
  • Gerdelat-Mas A, Loubinoux I, Tombari D, et al. Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects. Neuroimage 2005;27(2):314-22
  • Kline AE, Yu J, Massucci JL, et al. Protective effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin against traumatic brain injury-induced cognitive deficits and neuropathology in adult male rats. Neurosci Lett 2002;333(3):179-82
  • Wiart L, Petit H, Joseph PA, et al. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke 2000;31(8):1829-32
  • Arce E, Simmons AN, Lovero KL, et al. Escitalopram effects on insula and amygdala BOLD activation during emotional processing. Psychopharmacology (Berl) 2008;196(4):661-72
  • Paranthaman R, Baldwin RC. Treatment of psychiatric syndromes due to cerebrovascular disease. Int Rev Psychiatry 2006;18(5):453-70
  • Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U. Early fluoxetine treatment of post-stroke depression–a three-month double-blind placebo-controlled study with an open-label long-term follow up. J Neurol 2003;250(3):347-51
  • Dam M, Tonin P, De Boni A, et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996;27(7):1211-4
  • Pariente J, Loubinoux I, Carel C, et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol 2001;50(6):718-29
  • Robinson RG, Schultz SK, Castillo C, et al. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry 2000;157(3):351-9
  • Zittel S, Weiller C, Liepert J. Reboxetine improves motor function in chronic stroke. A pilot study. J Neurol 2007;254(2):197-201
  • Zittel S, Weiller C, Liepert J. Citalopram improves dexterity in chronic stroke patients. Neurorehabil Neural Repair 2008;22(3):311-4
  • Laska AC, von Arbin M, Kahan T, et al. Long-term antidepressant treatment with moclobemide for aphasia in acute stroke patients: a randomised, double-blind, placebo-controlled study. Cerebrovasc Dis 2005;19(2):125-32
  • Berthier ML, Hinojosa J, Martin Mdel C, Fernandez I. Open-label study of donepezil in chronic poststroke aphasia. Neurology 2003;60(7):1218-9
  • Berthier ML, Pujol J, Gironell A, et al. Beneficial effect of donepezil on sensorimotor function after stroke. Am J Phys Med Rehabil 2003;82(9):725-9
  • Bakheit AM. Drug treatment of poststroke aphasia. Expert Rev Neurother 2004;4(2):211-7
  • Kessler J, Thiel A, Karbe H, Heiss WD. Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. Stroke 2000;31(9):2112-6
  • Enderby P, Broeckx J, Hospers W, et al. Effect of piracetam on recovery and rehabilitation after stroke: a double-blind, placebo-controlled study. Clin Neuropharmacol 1994;17(4):320-31
  • Huber W, Willmes K, Poeck K, et al. Piracetam as an adjuvant to language therapy for aphasia: a randomized double-blind placebo-controlled pilot study. Arch Phys Med Rehabil 1997;78(3):245-50
  • De Deyn PP, Reuck JD, Deberdt W, et al. Treatment of acute ischemic stroke with piracetam. members of the piracetam in acute stroke study (PASS) group. Stroke 1997;28(12):2347-52
  • Huber W. The role of piracetam in the treatment of acute and chronic aphasia. Pharmacopsychiatry 1999;32(Suppl 1):38-43
  • Ricci S, Celani MG, Cantisani AT, Righetti E. Piracetam for acute ischaemic stroke. Cochrane Database Syst Rev 2006;(2):CD000419
  • Greener J, Enderby P, Whurr R. Pharmacological treatment for aphasia following stroke. Cochrane Database Syst Rev 2001;(4):CD000424
  • Duncan PW, Zorowitz R, Bates B, et al. Management of adult stroke rehabilitation care: a clinical practice guideline. Stroke 2005;36(9):e100-43
  • Romano JG, Sacco RL. Progress in secondary stroke prevention. Ann Neurol 2008;63:418-27
  • Chen J, Zhang ZG, Li Y, et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 2003;53(6):743-51
  • Blanco M, Nombela F, Castellanos M, et al. Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 2007;69(9):904-10
  • Shyu WC, Lin SZ, Yang HI, et al. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 2004;110(13):1847-54
  • Zhao LR, Singhal S, Duan WM, et al. Brain repair by hematopoietic growth factors in a rat model of stroke. Stroke 2007;38(9):2584-91
  • Sehara Y, Hayashi T, Deguchi K, et al. Potentiation of neurogenesis and angiogenesis by G-CSF after focal cerebral ischemia in rats. Brain Res 2007;1151:142-9
  • Ehrenreich H, Hasselblatt M, Dembowski C, et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002;8(8):495-505
  • Kleim JA, Chan S, Pringle E, et al. BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex. Nat Neurosci 2006;9(6):735-7
  • Lindvall O, Kokaia Z. Recovery and rehabilitation in stroke. Stem cells. Stroke 2004;35(Suppl 1):2691-4
  • Cairns K, Finklestein S. Growth factors and stem cells as treatments for stroke recovery. Phys Med Revabil Clin N Am 2003;14:135-42
  • Pastori C, Librizzi L, Breschi GL, et al. Arterially perfused neurosphere-derived cells distribute outside the ischemic core in a model of transient focal ischemia and reperfusion in vitro. PLoS ONE 2008;3(7):e2754
  • Sprigg N, Bath P. Pharmacological enhancement of recovery from stroke. Curr Med Lit Stroke Rev 2005;8:33-9
  • Wilson MS, Gibson CJ, Hamm RJ. Haloperidol, but not olanzapine, impairs cognitive performance after traumatic brain injury in rats. Am J Phys Med Rehabil 2003;82(11):871-9
  • Sims JS, Jones TA, Fulton RL. Benzodiazepines effects on recovery of function linked to transneuronal morphological events. Soc Neurosci Abstr 1990;16:342
  • Lazar RM, Fitzsimmons BF, Marshall RS, et al. Midazolam challenge reinduces neurological deficits after transient ischemic attack. Stroke 2003;34(3):794-6
  • Gelber DA, Good DC, Dromerick A, et al. Open-label dose-titration safety and efficacy study of tizanidine hydrochloride in the treatment of spasticity associated with chronic stroke. Stroke 2001;32(8):1841-6
  • Bates B, Choi JY, Duncan PW, et al. US Department of Defense; Department of Veterans Affairs. Veterans Affairs/Department of Defense Clinical Practice Guideline for the Management of Adult Stroke Rehabilitation Care: executive summary. Stroke 2005;36(9):2049-56
  • Goldstein LB. Potential effects of common drugs on stroke recovery. Arch Neurol 1998;55(4):454-6
  • Hasselt PV. Effect of butyrophenones on motor function in rats after recovery from brain damage. Neuropharmacology 1973;12(3):245-7
  • Feeney DM, Westerberg VS. Norepinephrine and brain damage: alpha noradrenergic pharmacology alters functional recovery after cortical trauma. Can J Psychol 1990;44(2):233-52
  • Rosser N, Floel A. Pharmacological enhancement of motor recovery in subacute and chronic stroke. NeuroRehabilitation 2008;23(1):95-103
  • Leśniak M, Bak T, Czepiel W, et al. The frequency and prognostic value of cognitive disorders in stroke patients. Dement Geriatr Cogn Disord 2008;26:356-63
  • Liepert J. Pharmacotherapy in restorative neurology. Curr Opin Neurol 2008;21:639-43

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.